Based on this hypothesis, we focus on the role of TARDBP transcriptional redundancy in the pathogenesis of ALS and propose a treatment strategy to control abnormal TDP-43 metabolism in patients with ALS. The gene discussed is TARDBP; the disease is amyotrophic lateral sclerosis.